EDGAR Filing Documents for 0001654954-18-002051

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001654954-18-002051

Filing Date

2018-03-01

Accepted

2018-03-01 16:08:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	gtbp_s3.htm	S-3	486473
2	OPINION ON LEGALITY	gtbp_ex51.htm	EX-5.1	12097
3	CONSENTS OF EXPERTS AND COUNSEL	gtbp_ex231.htm	EX-23.1	4518
4	IMAGE	img001.jpg	GRAPHIC	5786
	Complete submission text file	0001654954-18-002051.txt		512468

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)